Profile
Sector:
HealthcareIndustry:
Diagnostics & ResearchCountry:
United StatesIPO:
09 May 2013Website:
http://www.iqvia.comNext earnings report:
14 February 2025Last dividends:
N/ANext dividends:
N/APrice
after hours | Thu, 21 Nov 2024 00:47:04 GMTDividend
Analysts recommendations
Institutional Ownership
Included in screeners
IQV Latest News
Assess IQVIA's (IQV) dependence on revenue from international markets to gain insights into the company's financial health, growth potential, and possible stock price trends. This analysis can help determine how well the company might perform in the future.
The growth in IQV's revenue during the third quarter of 2024 is supported by strong performance in the Research and Development, as well as the Technology and Analytics areas.
IQVIA Holdings (IQV) reported quarterly earnings of $2.84 per share, which is higher than the Zacks Consensus Estimate of $2.81 per share. This is an increase compared to earnings of $2.49 per share from the same period last year.
On Thursday, the contract research company IQVIA reduced its yearly revenue predictions because two clinical trials have been delayed, as one of its clients is experiencing logistical issues.
IQV's revenues from TAS and RD&S are expected to rise, while CSMS revenues are probably going to decrease in the third quarter of 2024.
IQV enjoys advantages from being a market leader, its focus on data-driven innovation, and its growth around the world. However, it also faces challenges related to pricing pressures.
IQVIA has a large database and specialized IT systems for healthcare, along with data analysis advancements, which help it expand in the $300 billion market.
RBC Capital Markets has started to analyze IQVIA Holdings Inc. (IQV), highlighting that the company's main advantage is its valuable data resources. The analyst points out that IQVIA is the largest contract research organization in the world.
On September 4, 2024, in Philadelphia, Signant Health, a top company in evidence generation for contemporary clinical trials, revealed that it has partnered with IQVIA. IQVIA is a prominent global provider of advanced analytics, technology solutions, and clinical research services for the life sciences sector. Together, they are working on the One Home for Sites™ initiative.
IQVIA (IQV) shared its earnings report 30 days ago. What can we expect for the stock moving forward?
What type of business is IQVIA Holdings?
IQVIA Holdings Inc. is a provider of advanced analytical, technological solutions and contract research services for the life sciences industry. The company was founded in 1982 as Quintiles IMS Holdings, Inc. and changed its name to its current one in November 2017. The corporate headquarters are located in Durham, North Carolina. The company's activities are carried out through three reporting segments: - Technologies and Analytics - solutions provide critical information, technological solutions, and services for clients in the life sciences industry. - Research and Development - provides services for clinical research and clinical trials for biopharmaceutical companies. - Contract Sales and Medical Solutions - provide contract sales for clients of biopharmaceutical products as well as for the broader healthcare market.
What sector is IQVIA Holdings in?
IQVIA Holdings is in the Healthcare sector
What industry is IQVIA Holdings in?
IQVIA Holdings is in the Diagnostics & Research industry
What country is IQVIA Holdings from?
IQVIA Holdings is headquartered in United States
When did IQVIA Holdings go public?
IQVIA Holdings initial public offering (IPO) was on 09 May 2013
What is IQVIA Holdings website?
https://www.iqvia.com
Is IQVIA Holdings in the S&P 500?
Yes, IQVIA Holdings is included in the S&P 500 index
Is IQVIA Holdings in the NASDAQ 100?
No, IQVIA Holdings is not included in the NASDAQ 100 index
Is IQVIA Holdings in the Dow Jones?
No, IQVIA Holdings is not included in the Dow Jones index
When was IQVIA Holdings the previous earnings report?
No data
When does IQVIA Holdings earnings report?
The next expected earnings date for IQVIA Holdings is 14 February 2025